Lv1
50 积分 2025-06-28 加入
The New Lung Cancer Staging System
3个月前
已关闭
Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib
3个月前
已完结
Efficacy and Safety of EGFR-TKI Combined With Early Brain Radiotherapy Versus TKI Alone in Patients With EGFR-Mutated NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis
3个月前
已完结
Unlocking the potential: tissue mutation abundance as a predictor for third-generation EGFR-TKI efficacy in NSCLC
3个月前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
3个月前
已完结
Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity
3个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches
3个月前
已完结
Small Cell Lung Cancer: A Review
3个月前
已完结
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases
4个月前
已完结
Thoracic radiotherapy synergizes with first-line EGFR-TKIs in advanced EGFR-mutant NSCLC: A dual-center real-world study
4个月前
已完结
皖公网安备34019202002308
